182 related articles for article (PubMed ID: 23783833)
21. Prices and mark-ups on antimalarials: evidence from nationally representative studies in six malaria-endemic countries.
Palafox B; Patouillard E; Tougher S; Goodman C; Hanson K; Kleinschmidt I; Torres Rueda S; Kiefer S; O'Connell K; Zinsou C; Phok S; Akulayi L; Arogundade E; Buyungo P; Mpasela F; Poyer S; Chavasse D
Health Policy Plan; 2016 Mar; 31(2):148-60. PubMed ID: 25944705
[TBL] [Abstract][Full Text] [Related]
22. The quest for universal access to effective malaria treatment: how can the AMFm contribute?
Matowe L; Adeyi O
Malar J; 2010 Oct; 9():274. PubMed ID: 20932286
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of malaria parasitemia and purchase of artemisinin-based combination therapies (ACTs) among drug shop clients in two regions in Tanzania with ACT subsidies.
Briggs MA; Kalolella A; Bruxvoort K; Wiegand R; Lopez G; Festo C; Lyaruu P; Kenani M; Abdulla S; Goodman C; Kachur SP
PLoS One; 2014; 9(4):e94074. PubMed ID: 24732258
[TBL] [Abstract][Full Text] [Related]
24. The cost of uncomplicated childhood fevers to Kenyan households: implications for reaching international access targets.
Larson BA; Amin AA; Noor AM; Zurovac D; Snow RW
BMC Public Health; 2006 Dec; 6():314. PubMed ID: 17196105
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness analysis of introducing malaria diagnostic testing in drug shops: A cluster-randomised trial in Uganda.
Hansen KS; Clarke SE; Lal S; Magnussen P; Mbonye AK
PLoS One; 2017; 12(12):e0189758. PubMed ID: 29244829
[TBL] [Abstract][Full Text] [Related]
26. Assessing availability, prices, and market share of quality-assured malaria ACT and RDT in the private retail sector in Nigeria and Uganda.
Woldeghebriel M; Aso E; Berlin E; Fashanu C; Kirumira SN; Lam F; Mugerwa R; Nakiganda J; Olaleye T; Opigo J; Osinupebi F; Priestley N; Stringham R; Uhomoibhi P; Visser T; Ward A; Wiwa O; Woolsey A
Malar J; 2024 Feb; 23(1):41. PubMed ID: 38321459
[TBL] [Abstract][Full Text] [Related]
27. Impact of Improving Community-Based Access to Malaria Diagnosis and Treatment on Household Costs.
Castellani J; Nsungwa-Sabiiti J; Mihaylova B; Ajayi IO; Siribié M; Afonne C; Balyeku A; Sermé L; Sanou AK; Sombié BS; Tiono AB; Sirima SB; Kabarungi V; Falade CO; Kyaligonza J; Evers SM; Paulus AT; Petzold M; Singlovic J; Gomes M
Clin Infect Dis; 2016 Dec; 63(suppl 5):S256-S263. PubMed ID: 27941102
[TBL] [Abstract][Full Text] [Related]
28. Willingness-to-pay for a rapid malaria diagnostic test and artemisinin-based combination therapy from private drug shops in Mukono District, Uganda.
Hansen KS; Pedrazzoli D; Mbonye A; Clarke S; Cundill B; Magnussen P; Yeung S
Health Policy Plan; 2013 Mar; 28(2):185-96. PubMed ID: 22589226
[TBL] [Abstract][Full Text] [Related]
29. Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries.
O'Connell KA; Gatakaa H; Poyer S; Njogu J; Evance I; Munroe E; Solomon T; Goodman C; Hanson K; Zinsou C; Akulayi L; Raharinjatovo J; Arogundade E; Buyungo P; Mpasela F; Adjibabi CB; Agbango JA; Ramarosandratana BF; Coker B; Rubahika D; Hamainza B; Chapman S; Shewchuk T; Chavasse D
Malar J; 2011 Oct; 10():326. PubMed ID: 22039838
[TBL] [Abstract][Full Text] [Related]
30. Access to subsidized artemether-lumefantrine from the private sector among febrile children in rural setting in Kilosa, Tanzania.
Simba D; Kakoko D
Tanzan J Health Res; 2012 Apr; 14(2):89-95. PubMed ID: 26591729
[TBL] [Abstract][Full Text] [Related]
31. Improving access to malaria medicine through private-sector subsidies in seven African countries.
Tougher S; Mann AG; ; Ye Y; Kourgueni IA; Thomson R; Amuasi JH; Ren R; Willey BA; Ansong D; Bruxvoort K; Diap G; Festo C; Johanes B; Kalolella A; Mallam O; Mberu B; Ndiaye S; Nguah SB; Seydou M; Taylor M; Wamukoya M; Arnold F; Hanson K; Goodman C
Health Aff (Millwood); 2014 Sep; 33(9):1576-85. PubMed ID: 25201662
[TBL] [Abstract][Full Text] [Related]
32. Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania.
Sabot OJ; Mwita A; Cohen JM; Ipuge Y; Gordon M; Bishop D; Odhiambo M; Ward L; Goodman C
PLoS One; 2009 Sep; 4(9):e6857. PubMed ID: 19724644
[TBL] [Abstract][Full Text] [Related]
33. Caregivers' treatment-seeking behaviors and predictors of whether a child received an appropriate antimalarial treatment: a household survey in rural Uganda.
Kassam R; Sekiwunga R; Collins JB; Tembe J; Liow E
BMC Infect Dis; 2016 Sep; 16(1):478. PubMed ID: 27600604
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness analysis of malaria rapid diagnostic tests for appropriate treatment of malaria at the community level in Uganda.
Hansen KS; Ndyomugyenyi R; Magnussen P; Lal S; Clarke SE
Health Policy Plan; 2017 Jun; 32(5):676-689. PubMed ID: 28453718
[TBL] [Abstract][Full Text] [Related]
35. Towards subsidized malaria rapid diagnostic tests. Lessons learned from programmes to subsidise artemisinin-based combination therapies in the private sector: a review.
Lussiana C
Health Policy Plan; 2016 Sep; 31(7):928-39. PubMed ID: 25862732
[TBL] [Abstract][Full Text] [Related]
36. Communicating the AMFm message: exploring the effect of communication and training interventions on private for-profit provider awareness and knowledge related to a multi-country anti-malarial subsidy intervention.
Willey BA; Tougher S; Ye Y; ; Mann AG; Thomson R; Kourgueni IA; Amuasi JH; Ren R; Wamukoya M; Rueda ST; Taylor M; Seydou M; Nguah SB; Ndiaye S; Mberu B; Malam O; Kalolella A; Juma E; Johanes B; Festo C; Diap G; Diallo D; Bruxvoort K; Ansong D; Amin A; Adegoke CA; Hanson K; Arnold F; Goodman C
Malar J; 2014 Feb; 13():46. PubMed ID: 24495691
[TBL] [Abstract][Full Text] [Related]
37. Treatment-seeking patterns for malaria in pharmacies in five sub-Saharan African countries.
Ladner J; Davis B; Audureau E; Saba J
Malar J; 2017 Aug; 16(1):353. PubMed ID: 28851358
[TBL] [Abstract][Full Text] [Related]
38. Artemisinin combination therapies price disparity between government and private health sectors and its implication on antimalarial drug consumption pattern in Morogoro Urban District, Tanzania.
Malisa AL; Kiriba D
BMC Res Notes; 2012 Mar; 5():165. PubMed ID: 22455367
[TBL] [Abstract][Full Text] [Related]
39. Patients with positive malaria tests not given artemisinin-based combination therapies: a research synthesis describing under-prescription of antimalarial medicines in Africa.
O'Boyle S; Bruxvoort KJ; Ansah EK; Burchett HED; Chandler CIR; Clarke SE; Goodman C; Mbacham W; Mbonye AK; Onwujekwe OE; Staedke SG; Wiseman VL; Whitty CJM; Hopkins H
BMC Med; 2020 Jan; 18(1):17. PubMed ID: 31996199
[TBL] [Abstract][Full Text] [Related]
40. Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia.
Yeung S; Patouillard E; Allen H; Socheat D
Malar J; 2011 Aug; 10():243. PubMed ID: 21851625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
